Melorheostosis, A Rare Disease That Causes Chronic Pain: Efficacy of Pulsed Radiofrequency

Case Report

Austin J Anesthesia and Analgesia. 2020; 8(2): 1089.

Melorheostosis, A Rare Disease That Causes Chronic Pain: Efficacy of Pulsed Radiofrequency

Rodríguez-Navarro MA*, Alcaraz AB, Benitez M, Mula-Leal J, Padilla-Del Rey ML, Díaz C and Castillo JA

Department of Anenesthesia and Pain Management, General University Hospital, José María Morales Meseguer, Murcia, Spain

*Corresponding author: Maria Angeles Rodríguez Navarro, Department of Anenesthesia and Pain Management, General University Hospital, José María Morales Meseguer, Murcia, Spain

Received: May 27, 2020; Accepted: June 16, 2020; Published: June 23, 2020

Abstract

Melorheostosis is an exceptionally rare sclerosing hyperostosis. Recent studies of melorheostosis indicate that most cases arise from somatic MAP2K1 mutations, those cases are more likely to have the classic “dripping candle wax” appearance on radiographs. It has an incidence of 0.9 cases per million inhabitants and it is distributed equally between both sexes.

Why Melorheostosis is a syndrome that pain physician need to know? The presenting features of melorheostosis are variable, depending on the site and extent of the bone disease and whether there is any associated soft tissue involvement. Some cases are identified from incidental radiographic findings, but the most common syndrome there will be chronic pain. Despite this, there is no any publication in “pain management journals”.

In addition to drug treatment, which is in constant revision, we propose to apply Pulsed Radiofrequency of the nerves (PRF) to treat pain in melorheostosis based in the efficacy published.

We reported a case of 39-year-old male suffering 15 years of chronic hip pain because of Melorheostosis. The results of PRF of articular branches of femoral and obturator nerves have been very successful.

For radicular pain from spinal diseases, the evidence supports that PRF is an effective treatment. Similarly, PRF appears to be effective for post-herpetic neuralgia and occipital neuralgia. Nevertheless for others syndromes its effectiveness must be tested and even it is more necessary to communicate results in rare diseases as Melorheostosis which the number of treated patients is not very large.

Keywords: Melorheostosis; Melorheostosis; Pain Management; Hip Joint Pain; Pulsed Radiofrequency, Obturator and Femoral Nerves

Introduction

First described in 1922 as Leri’s disease, Melorheostosis is a rare sclerosing hyperostosis that typically affects the appendicular skeleton in a limited segmental fashion. It occasionally occurs on a background of another benign generalized sclerosing bone condition, known as osteopoikilosis caused by germline mutations in LEMD3, encoding the inner nuclear membrane protein MAN1, which modulates TGFß/bone morphogenetic protein signaling. Recent studies of melorheostosis lesioned tissue indicate that most cases arise from somatic MAP2K1 mutations, those cases are more likely to have the classic “dripping candle wax” appearance on radiographs. It has an incidence of 0.9 cases per million inhabitants and it is distributed equally between both sexes.

Why Melorheostosis is a syndrome that pain physician need to know? The presenting features of melorheostosis are variable, depending on the site and extent of the bone disease and whether there is any associated soft tissue involvement. Some cases are identified from incidental radiographic findings, but pain is the most common presenting concern (83%) [1,2].

Medical treatments have been tested include bisphosphonates, but there is not a definitive guidance on their use because of the small number of patients. Surgical intervention may be required for those with large bone growths, nerve entrapments, joint impingement syndromes or major limb deformities. Bone regrowth is possible after surgery and recurrent contractures represent a major issue in those with extensive associated soft tissue involvement [1,3].

Today, Chronic Pain Units offer pulsed radiofrequency (PRF), a new method in the treatment of pain which can be applied in Melorheostosis. For example, PRF of the articular branches of the femoral and obturator nerves offers a treatment option of hip pain [4,5].

Case Report

A 39-year-old male was referred to the Pain Unit for persistent pain after total hip replacement. After 15 years of chronic pain and different ineffective pharmacological treatments, hip arthroscopy was performed that visualized areas of intra-articular bone growth that were removed. A postoperative radiology control showed different areas of these growing and a cortical thickening of the femur was noted (Figure 1). Analytics, including acute phase reactants, were normal. Bone scintigraphy shows tracer hypercaptation in the right internal femoral cortex with bone cortex hypertrophy and proximal third of the right tibia compatible with Melorheostosis syndrome.